BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23507851)

  • 1. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
    Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
    J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.
    Xi L; Grobmyer SR; Zhou G; Qian W; Yang L; Jiang H
    J Biophotonics; 2014 Jun; 7(6):401-9. PubMed ID: 23125139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
    Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
    Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Evaluation of a Miniaturized Fluorescence Molecular Tomography (FMT) Endoscope for Breast Cancer Detection Using Targeted Nanoprobes.
    Yang H; Qian W; Yang L; Xie H; Jiang H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tumor targeting drug carrier for optical imaging and therapy.
    Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
    Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
    Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
    Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging.
    Zhou X; Zheng K; Li R; Chen Z; Yuan C; Hu P; Chen J; Xue J; Huang M
    Acta Biomater; 2015 Sep; 23():116-126. PubMed ID: 26004218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
    Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
    Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
    ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR).
    Liu D; Overbey D; Watkinson L; Giblin MF
    Bioconjug Chem; 2009 May; 20(5):888-94. PubMed ID: 19354275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
    Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
    Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
    Abdalla MO; Karna P; Sajja HK; Mao H; Yates C; Turner T; Aneja R
    J Control Release; 2011 Feb; 149(3):314-22. PubMed ID: 21047537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
    Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
    J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
    Jo M; Takimoto S; Montel V; Gonias SL
    Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.